Gulf Coast Regional Blood Center has hosted an annual lecture in transfusion medicine for 21 years. The Blood Center's Board of Trustees renamed the lecture "The Bill T. Teague Lectureship in Transfusion Medicine" on the recommendation of the Education and Research Committee in 1996.
The name recognizes contributions to the field of blood banking and transfusion medicine by Bill T. Teague, The Blood Center's founding CEO, who served in that capacity for more than 30 years.
The purpose of the event is to present lectures by nationally recognized authorities in all areas of transfusion medicine, blood banking science, administration and technology.
APRIL 14, 2020
Andrew Cap, M.D., Ph.D., FACP
Chief, Blood Research, Us Army Institute Of Surgical Research
Cold Stored Platelets
Jay Menitove, MD
Former CEO/Medical Director
Community Blood Center of Greater Kansas City
U.S. Blood System: Safety, Availability, and Thoughts About the Future
Susan Stramer, Ph.D
Vice President, Scientific Affairs
American Red Cross
Back to the Future: A Retrospective Journey in Blood Safety
Over the past 30 years, there has been a continued progress in blood safety with respect to transmissible diseases. This lecture will describe interventions used to improve blood safety relative to existing and emerging infectious agents, as well as describe future technologies and evolving threats.
Dennis L. Confer, MD
Chief Medical Officer, National Marrow Donor Program
Associate Scientific Director, CIBMTR®
National Marrow Donor Program and Be The Match: 30 Years Strong
Over the past 30 years, the source of cells for allogeneic transplantation has evolved to improve access and outcomes for patients with a variety of malignant and non-malignant disease. This talk will review the past and current utilization of bone marrow, peripheral blood stem cells and cord blood in related and unrelated settings. The talk will also touch on implications for the role of registries and networks in meeting the needs of patients in the future.
Louis M. Katz, MD
Chief Medical Officer
America's Blood Centers
How much safety is enough? (and who decides?)
Emerging infections have been at the center of blood safety for decades. With control of the historic risks, hepatitis viruses and HIV, we are facing different qualitative and quantitative issues, and an expanding list of agents have our attention. The agents of interest and the options for mitigation of risk will be reviewed, including pathogen reduction, which offers a proactive approach for these concerns.
Merlyn H. Sayers, MBBCh, PhD
President and Chief Executive Officer
Carter BloodCare, Bedford, Texas
Old Donors, Old Blood, Old Guidelines:
What is New?
Blood bankers, until relatively recently, were mainly concerned about transfusion-transmitted infection. With improvements in test sensitivity, priorities have changed. This lecture addresses future potentials for conflict with donors, regulators, hospitals and patients.
Arthur Bracey, MD
Baylor St. Luke's Medical Center, Houston, Texas
The Blood Interface in Cardiovascular Surgery: The Known and Unknown
Dr. Bracey reviewed blood therapy and conservation in the cardiovascular surgery setting, and discussed issues that have been solved and persisting uncertainties in need of further study.
Areyh Shander, MD
Chief of the Department of Anesthesiology,
Critical Care Medicine, Pain Management, and Hyperbaric Medicine
Englewood Hospital and Medical Center, New Jersey
When Blood is Not an Option
John B. Holcomb, MD, FACS
Vice Chair and Professor of Surgery,
Director of Center for Translational Injury Research
University of Texas Health Science Center at Houston
Damage Control Resuscitation
MAY 19, 2011
Celso Bianco, MD
Executive Vice President
America's Blood Centers
Blood Transfusion: How Safe is Safe?
George Garratty, PhD
FRCPath, Scientific Director, American Red Cross Blood Services, Southern California Region
"What Are Blood Groups For - Do They Play A Biological Role?"
Mark Popovsky, MD
"To Breathe or Not to Breathe: Pulmonary Consequences of Transfusion"
Harvey Klein, M.D.
"Pathogen Inactivation of Blood Components - the Consensus Conference and Beyond"
For more information, you can contact us at firstname.lastname@example.org.